Table 3.
Associations between White Race and Clinical Trial Enrollment Controlling for Demographic and Psychosocial Characteristics
| No. of subjects | AOR (95% CI)a | P value | |
|---|---|---|---|
| White race (base model) | 356 | 2.70 (1.09–6.69)b | 0.03 |
| Plus age | 356 | 3.15 (1.24–8.00) | 0.02 |
| Plus male | 356 | 2.75 (1.11–6.83) | 0.03 |
| Plus health insured | 350 | 1.33 (0.50–3.58) | 0.57 |
| Plus education | 356 | 2.38 (0.89–6.41) | 0.09 |
| Plus Protestant religion | 356 | 2.94 (1.18–7.33) | 0.02 |
| Plus Jewish religion | 356 | 2.37 (0.94–5.97) | 0.07 |
| Plus Baptist religion | 356 | 2.42 (0.97–6.06) | 0.06 |
| Plus Yale Cancer Center | 356 | 1.96 (0.76–5.07) | 0.17 |
| Plus Parkland Hospital | 356 | 1.13 (0.40–3.22) | 0.82 |
| Plus New Hampshire Heme/Onc | 356 | 3.59 (1.44–9.00) | 0.006 |
| Plus Pancreatic cancer | 356 | 2.30 (0.91–5.79) | 0.08 |
| Plus Brain cancer | 356 | 2.62 (1.05–6.52) | 0.04 |
| Plus Lung cancer | 356 | 2.78 (1.12–6.93) | 0.03 |
| Plus Esophageal cancer | 356 | 2.72 (1.09–6.76) | 0.03 |
| Plus Karnofsky score | 348 | 2.56 (1.02–6.41) | 0.04 |
| Plus Zubrod score | 350 | 2.61 (1.05–6.50) | 0.04 |
| Plus Charlson Index | 355 | 2.96 (1.19–7.41) | 0.02 |
| Plus End-of-life discussion | 355 | 3.18 (1.27–7.97) | 0.01 |
| Plus want doctor to tell life-expectancy | 325 | 3.33 (1.22–9.05) | 0.02 |
| Plus general self-efficacy | 317 | 2.94 (1.09–7.95) | 0.03 |
| Plus extend life preference | 289 | 3.02 (1.08–8.40) | 0.03 |
| Plus prefer chemotherapy | 319 | 3.26 (1.20–8.83) | 0.02 |
| Plus completed DNR order | 322 | 3.73 (1.37–10.19) | 0.01 |
| Plus McGill symptoms | 354 | 2.99 (1.19–7.50) | 0.02 |
a
The adjusted ORs account for demographic and psychosocial variables.
b
The OR for the base model is unadjusted.
Sample sizes vary due to missing data.
AOR, adjusted odds ratio; CI, confidence interval; DNR, do not resuscitate.
Bold indicates no statistical significance.